The blood processing devices and consumables market is anticipated to reach around USD 51 billion by 2022. It has a growth rate of about 7.8% from 2015 to 2022 (forecast phase). This growth may be attributed to chronic diseases that require surgeries and blood transfusion for their treatment. Thus, surgeries and organ transplants would drive demand for these devices in the forecast phase. Also, the escalating elderly population fuels the market.
For Market Research Report on “Blood Processing Devices and Consumables Market” Visit -http://www.radiantinsights.com/research/global-blood-processing-devices-industry-2015-market-research-report
Cell processors, hematocrit centrifuges, blood bank freezers, blood bank refrigerators, grouping analyzers, and warmers are the blood processing devices products. Consumables encompass blood coagulation reagents, blood grouping reagents, hematology reagents, sedimentation tubes, blood administration sets, blood lancets, and blood filters. Blood collection tubes, blood bags, blood filters, vials, test tube racks, slide stainers, and slides are the remaining consumables products.
Blood processing devices contributed over 60% of the overall market in 2014. Hematocrit centrifuges and cell processors jointly captured about half of the total shares in 2014. Cell processing novel technologies like density gradient separation and some others are expected to favor the blood processing devices and consumables market. Stringent guidelines regarding storage requirements of blood fluid components will offer lucrative prospects to blood bank refrigerators.
Consumables would witness significant growth due to introduction of plasma filters in collection tubes. The development of point-of-care hematology testing centers is estimated to guarantee the raised sales of hematology reagents and administration sets over the next seven years.
North America generated over 33% share in the blood processing devices and consumables market in 2014. Car crashes, chronic diseases, and hospital emergencies in the region accounted for its big share. Asia Pacific will experience around 8% CAGR during 2015 to 2022. This would happen on account of burgeoning population and epidemic diseases in the region. Sophisticated healthcare and government-led initiatives supporting blood processing are expected to favor Asia Pacific.
Major players in the worldwide blood processing devices and consumables market are Bio-Rad Laboratories, Haemonetics Corporation, Grifols International, Terumo Corporation, and Abbott Laboratories. They are incorporating automated technology to aid plasma and serum processing. One of their expansion strategies includes collaborations with blood banks and hospitals.
Information Source: Radiants Insights